Pharmacodynamic case study of sunitinib/SU11248 in a gastrointestinal stromal tumor patient: Evidence toward a mechanism of effect

MLA

Marco Seandel, et al. “Pharmacodynamic Case Study of Sunitinib/SU11248 in a Gastrointestinal Stromal Tumor Patient: Evidence toward a Mechanism of Effect.” Journal of Clinical Oncology, vol. 24, June 2006, p. 9526. EBSCOhost, https://doi.org/10.1200/jco.2006.24.18_suppl.9526.

APA

Marco Seandel, C. R. Antonescu, Robert G. Maki, Jakob Dupont, Jinru Shia, & Irina Linkov. (2006). Pharmacodynamic case study of sunitinib/SU11248 in a gastrointestinal stromal tumor patient: Evidence toward a mechanism of effect. Journal of Clinical Oncology, 24, 9526. https://doi.org/10.1200/jco.2006.24.18_suppl.9526

Chicago

Marco Seandel, C. R. Antonescu, Robert G. Maki, Jakob Dupont, Jinru Shia, and Irina Linkov. 2006. “Pharmacodynamic Case Study of Sunitinib/SU11248 in a Gastrointestinal Stromal Tumor Patient: Evidence toward a Mechanism of Effect.” Journal of Clinical Oncology 24 (June): 9526. doi:10.1200/jco.2006.24.18_suppl.9526.